Free radicals and birth defects

References

• White P. Pregnancy complicating diabetes. In The Treatment of Diabetes Mellitus. Philadelphia: Lea & Febiger, 1937
   Google Scholar
• Becerra JE, Khoury MJ, Cordero JF, et al. Diabetesmellitus during pregnancy and the risks for the specific birth defects: a population-based case–control study. Pediatrics 1990;85:1–9
   PubMed Web of Science ®Google Scholar
• Loffredo CA, Wilson PD, Ferencz C. Maternal diabetes: an independent risk factor for major cardiovascular malformations with increased mortality of affected infants. Teratology 2001;64:98–106
   Google Scholar
• Aberg A, Westbom L, Kallen B. Congenital malformations among infantswhos e mothershad gestational diabetesor preexisting diabetes. Early Hum Dev 2001;61:85–95
   Google Scholar
• Sheffield JS, Butler-Koster EL, Casey BM, et al. Maternal diabetesmellitusand infant malformations. Obstet Gynecol 2002;100:925–30
   PubMed Web of Science ®Google Scholar
• Langer O, Conway DL. Level of glycemia and perinatal outcome in pregestational diabetes. J Matern Fetal Med 2000;9:35–41
   PubMedGoogle Scholar
• Schaefer-Graf UM, Buchanan TA, Xiang A, et al. Patterns of congenital anomaliesand relationship to initial maternal fasting glucose levels in pregnancies complicated by type 2 and gestational diabetes. Am J Obstet Gynecol 2000;182: 313–20
   Google Scholar
• Lauenborg J, Mathiesen E, Ovesen P, et al. Audit on stillbirths in women with pregestational type 1 diabetes. Diabetes Care 2003;26:1385–9
   PubMed Web of Science ®Google Scholar
• Group TDR. Pregnancy outcomesin the DiabetesControl and ComplicationsTrial. Am J Obstet Gynecol 1996;174: 1343–53
   PubMed Web of Science ®Google Scholar
• Towner D, KjosSL, Leung B, et al. Congenital malformations in pregnanciescomplicated by NIDDM. Diabetes Care1995;18:1446–51
   PubMed Web of Science ®Google Scholar
• Watkins ML, Rasmussen SA, Honein MA, et al. Maternal obesity and risk for birth defects. Pediatrics 2003;111:1152–8
   PubMed Web of Science ®Google Scholar
• Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature (London) 2001;414:813–20
   PubMed Web of Science ®Google Scholar
• WellsPG, Winn LM. Biochemical toxicology of chemical teratogenesis. Crit Rev Biochem Mol Biol 1996;31:1–40
   PubMed Web of Science ®Google Scholar
• Parman T, Wiley MJ, WellsPG. Free radical-mediated oxidative DNA damage in the mechanism of thalidomide teratogenicity. Nature Med 1999;5:582–5
   Google Scholar
• Bankson DD, Kestin M, Rifai N. Role of free radicals in cancer and atherosclerosis. Clin Lab Med 1993;13:463–80
   Google Scholar
• Xu D, Finkel T.Arole for mitochondria aspotential regulators of cellular life span. Biochem Biophys Res Commun 2002;294:245–8
   PubMed Web of Science ®Google Scholar
• Xu D, Neville R, Finkel T. Homocysteine accelerates endothelial cell senescence. FEBS Lett 2000;470:20–4
   Google Scholar
• Nakano E, HigginsJA, PowersHJ. Folate protectsagains t oxidative modification of human LDL. Br J Nutr 2001;86:637–9
   Google Scholar
• Moley KH. Hyperglycemia and apoptosis: mechanisms for congenital malformationsand pregnancy lossin diabetic women. Trends Endocrinol Metab 2001;12:78–82
   PubMed Web of Science ®Google Scholar
• el-Hage S, Singh SM. Temporal expression of genes encoding free radical-metabolizing enzymes is associated with higher mRNA levelsduring in utero development in mice. DevGenet 1990;11:149–59
   Google Scholar
• Wentzel P, Eriksson UJ. Antioxidants diminish developmental damage induced by high glucose and cyclooxygenase inhibitors in rat embryos in vitro. Diabetes 1998;47:677–84
   PubMed Web of Science ®Google Scholar
• Siman CM, Eriksson UJ. Vitamin C supplementation of the maternal diet reducesthe rate of malformation in the offspring of diabetic rats. Diabetologia 1997;40:1416–24
   PubMed Web of Science ®Google Scholar
• Siman CM, Eriksson UJ. Vitamin E decreases the occurrence of malformations in the offspring of diabetic rats. Diabetes 1997;46:1054–61
   PubMed Web of Science ®Google Scholar
• Eriksson U, Siman CM. Pregnant diabetic rats fed the antioxidant butylated hydroxytoluene show decreased occurrence of malformations in offspring. Diabetes 1996;45:1497–502
   PubMed Web of Science ®Google Scholar
• Sivan E, Reece EA, Wu Y-K, et al. Dietary vitamin E prophylaxisand diabetic embryopathy: morphologic and biochemical analysis. Am J Obstet Gynecol 1996;175:793–9
   Google Scholar
• Viana M, Herrera E, Bonet B. Terotogenic effectsof diabetes mellitusin the rat. Prevention by vitamin E. Diabetologia1996;39:1041–6
   Google Scholar
• Hagay ZJ, Weiss Y, Zusman I, et al. Prevention of diabetesassociated embryopathy by overexpression of the free radical scavenger copper zinc superoxide dismutase in transgenic mouse embryos. Am J Obstet Gynecol 1995;173:1036–41
   PubMed Web of Science ®Google Scholar
• Trocino RA, Akazawa S, Ishibashi M, et al. Significance of glutathione depletion and oxidative stress in early embryogenesis in glucose-induced rat embryo culture. Diabetes1995;44:992–8
   PubMed Web of Science ®Google Scholar
• Phelan SA, Ito M, Loeken MR. Neural tube defectsin embryos of diabetic mice: role of the Pax-3 gene and apoptosis. Diabetes 1997;46: 1189–97
   Google Scholar
• Fine E, Horal M, Chang T, et al. Hyperglycemia is responsible for altered gene expression, apoptosis, and neural tube defects associated with diabetic pregnancy. Diabetes 1999;48:2454–62
   PubMed Web of Science ®Google Scholar
• Hill AL, Phelan SA, Loeken MR. Reduced expression of Pax-3 is associated with overexpression of cdc46 in the mouse embryo. Dev Genes Evolution 1998;208: 128–34
   Google Scholar
• Cai J, Phelan SA, Hill AL, et al. Identification of Dep-1, a new gene that isregulated by the transcription factor, Pax-3, asa marker for altered embryonic gene expression during diabetic pregnancy. Diabetes 1998;47:1803–5
   PubMed Web of Science ®Google Scholar
• Chang TI, Horal M, Jain S, et al. Oxidant regulation of gene expression and neural tube development: insights gained from diabetic pregnancy on molecular causes of neural tube defects. Diabetologia 2003;46:538–45
   PubMed Web of Science ®Google Scholar
• Sivan E, Lee YC, Wu YK, et al. Free radical scavenging enzymes in fetal dysmorphogenesis among offspring of diabetic rats. Teratology 1997;56:343–9
   PubMedGoogle Scholar
• Finkel T. Redox-dependent signal transduction. FEBS Lett 2000;476:52–4
   PubMed Web of Science ®Google Scholar
• Kanji MI, Toews ML, Carper WR. A kinetic study of glucose-6-phosphate dehydrogenase. J Biol Chem 1976;251: 2258–62
   Google Scholar
• Clough JR, Whittingham DG. Metabolism of [14]glucose by postimplantation mouse embryos in vitro. J Embryol Exp Morphol 1983;74:133–42
   PubMedGoogle Scholar
• Hiramatsu Y, Sekiguchi N, Hayashi M, et al. Diacylglycerol production and protein kinase C activity are increased in a mouse model of diabetic embryopathy. Diabetes 2002;51:2804–10
   PubMed Web of Science ®Google Scholar
• Wentzel P, Ejdesjo A, Eriksson UJ. Maternal diabetes in vivo and high glucose in vitro diminish GAPDH activity in rat embryos. Diabetes 2003;52:1222–8
   Google Scholar
• Zheng L, Roeder RG, Luo Y. S phase activation of the histone H2B promoter by OCA-S, a coactivator complex that containsGAPDH asa key component. Cell 2003;114: 255–66
   Google Scholar
• Hainaut P. The tumor suppressor protein p53: a receptor to genotoxic stress that controls cell growth and survival. Curr Opin Oncol 1995;7:76–82
   PubMedGoogle Scholar
• Pani L, Horal M, Loeken MR. Rescue of neural tube defects in Pax-3-deficient embryosby p53 lossof function: implications for Pax-3-dependent development and tumorigenesis. Genes Dev 2002;16: 676–80
   Google Scholar
• Keim AL, Chi MM, Moley KH. Hyperglycemia-induced apoptotic cell death in the mouse blastocyst is dependent on expression of p53. Mol Reprod Dev 2001;60: 214–24
   Google Scholar
• Lotem J, Peled-Kamar M, Groner Y, et al. Cellular oxidative stress and the control of apoptosis by wild-type p53, cytotoxic compounds, and cytokines. Proc Natl Acad Sci USA 1996;93:9166–71
   PubMed Web of Science ®Google Scholar
• Sure B. Dietary requirementsfor reproduction. II. The existence of a specific vitamin for reproduction. J Biol Chem 1923;58:693–709
   Google Scholar
• Evans HM, Bishop KS. The production of sterility with nutritional regimesadequate for growth and itscure with other foodstuffs. J Metab Res 1923;3:233–316
   Google Scholar
• Verma K, King DW. Disorders of the developing nervous system of vitamin E-deficient rats. Acta Anat 1967;67:623–35
   PubMedGoogle Scholar
• Rosenquist TH, Ratashak SA, Selhub J. Homocysteine inducescongenital defectsof the heart and neural tube: effect of folic acid. Proc Natl Acad Sci USA 1996;93:15227–32
   Google Scholar
• Reece E, Homko C, Wu U, et al. The role of free radicalsand membrane lipidsin diabetes-induced congenital malformations. J Soc Gynecol Invest 1998;5:178–87
   PubMedGoogle Scholar